Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survival. [electronic resource]
Producer: 20040226Description: 28-35 p. digitalISSN:- 0301-472X
- Adult
- Aged
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Murine-Derived
- Female
- Graft vs Host Disease -- etiology
- Hematopoietic Stem Cell Transplantation
- Humans
- Immune Tolerance -- drug effects
- Leukemia, Lymphocytic, Chronic, B-Cell -- immunology
- Male
- Middle Aged
- Rituximab
- Transplantation, Homologous
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.